(Q45969591)

18 December 2017

title

URB597, an inhibitor of fatty acid amide hydrolase, reduces hyperalgesia in diabetic rats. (English)

1 reference

18 December 2017

0 references

1 reference

Parisa Hasanein

1

1 reference

18 December 2017

Mohsen Parviz

series ordinal

2

1 reference

18 December 2017

Mansoor Keshavarz

series ordinal

3

1 reference

18 December 2017

Ali Roohbakhsh

series ordinal

4

1 reference

18 December 2017

publication date

1 June 2009

1 reference

18 December 2017

Canadian Journal of Physiology and Pharmacology

published in

1 reference

18 December 2017

volume

87

1 reference

18 December 2017

issue

6

1 reference

18 December 2017

page(s)

432-439

1 reference

18 December 2017

The formalin test: scoring properties of the first and second phases of the pain response in rats.

cites work

1 reference

Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors

21 January 2018

1 reference

Prevention of sensory disorders in diabetic Sprague-Dawley rats by aldose reductase inhibition or treatment with ciliary neurotrophic factor

21 January 2018

1 reference

Gabapentin prevents hyperalgesia during the formalin test in diabetic rats

21 January 2018

1 reference

Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms

21 January 2018

1 reference

Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase

21 January 2018

1 reference

Formation and inactivation of endogenous cannabinoid anandamide in central neurons

21 January 2018

1 reference

Cannabinoids blocks tactile allodynia in diabetic mice without attenuation of its antinociceptive effect.

21 January 2018

1 reference

Increase of cannabinoid CB1 receptor density in the hippocampus of streptozotocin-induced diabetic rats.

21 January 2018

1 reference

Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation.

21 January 2018

1 reference

Critical evaluation of the streptozotocin model of painful diabetic neuropathy in the rat.

21 January 2018

1 reference

Elevated spinal cyclooxygenase and prostaglandin release during hyperalgesia in diabetic rats

21 January 2018

1 reference

Effects of neurotoxic destruction of descending noradrenergic pathways on cannabinoid antinociception in models of acute and tonic nociception

21 January 2018

1 reference

Oral magnesium administration prevents thermal hyperalgesia induced by diabetes in rats.

21 January 2018

1 reference

Endocannabinoid mechanisms of pain modulation

21 January 2018

1 reference

An endocannabinoid mechanism for stress-induced analgesia.

21 January 2018

1 reference

Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models

21 January 2018

1 reference

Endocannabinoid metabolism and uptake: novel targets for neuropathic and inflammatory pain

21 January 2018

1 reference

Modulation of anxiety through blockade of anandamide hydrolysis

21 January 2018

1 reference

Glycemic control of pain threshold in diabetic and control rats

21 January 2018

1 reference

Pain threshold in diabetic rats: effects of good versus poor diabetic control

21 January 2018

1 reference

Reversible inhibitors of fatty acid amide hydrolase that promote analgesia: evidence for an unprecedented combination of potency and selectivity

21 January 2018

1 reference

Analgesic actions of N-arachidonoyl-serotonin, a fatty acid amide hydrolase inhibitor with antagonistic activity at vanilloid TRPV1 receptors

21 January 2018

1 reference

A pharmacologic analysis of mechanical hyperalgesia in streptozotocin/diabetic rats

21 January 2018

1 reference

Anti-nociceptive effects of the GM1 ganglioside derivative AGF 44 on the formalin test in normal and streptozotocin-diabetic rats

21 January 2018

1 reference

Morphine analgesia in the formalin test: reversal by microinjection of quaternary naloxone into the posterior hypothalamic area or periaqueductal gray.

21 January 2018

1 reference

Intrathecal GM1 ganglioside and local nerve anesthesia reduce nociceptive behaviors in rats with experimental peripheral mononeuropathy

21 January 2018

1 reference

Structure and function of fatty acid amide hydrolase

21 January 2018

1 reference

Update on the pathogenesis of diabetic neuropathy

21 January 2018

1 reference

Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597).

21 January 2018

1 reference

The fatty acid amide hydrolase inhibitor URB597 (cyclohexylcarbamic acid 3'-carbamoylbiphenyl-3-yl ester) reduces neuropathic pain after oral administration in mice

21 January 2018

1 reference

Peripheral neuropathy does not invariably coexist with autonomic neuropathy in diabetes mellitus.

21 January 2018

1 reference

The effect of WIN 55,212-2, a cannabinoid agonist, on tactile allodynia in diabetic rats.

21 January 2018

1 reference

A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population

21 January 2018

1 reference

Spinal and supraspinal components of opioid antinociception in streptozotocin induced diabetic neuropathy in rats

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1139/Y09-026

1 reference

18 December 2017

PubMed ID

19526037

1 reference

18 December 2017